Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the REMODEL randomized trial - Eriksson, B.I; Dahl, OE; Rosencher, N (J Thromb Haemost, 2007)
et al.